Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications

Meningiomas account for approximately 30% of all new diagnoses of intracranial masses. The 2016 World Health Organization’s (WHO) classification currently represents the clinical standard for meningioma’s grading and prognostic stratification. However, watchful waiting is frequently the chosen treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Laudicella, Riccardo, Albano, Domenico, Annunziata, Salvatore, Calabrò, Diletta, Argiroffi, Giovanni, Abenavoli, Elisabetta, Linguanti, Flavia, Vento, Antonio, Bruno, Antonio, Alongi, Pierpaolo, Bauckneht, Matteo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826849/
https://ncbi.nlm.nih.gov/pubmed/31546734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101412
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados